BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1078621)

  • 1. Theoretical approach to molecular biology of factor VIII: heterogeneity of the molecule.
    Gralnick HR; Marchesi SL; Coller BS
    Ann N Y Acad Sci; 1975 Jan; 240():378-88. PubMed ID: 1078621
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic evidence that the antihemophilic factor (factor VIII)-like material in hemophilic plasma possesses a nonfunctional low molecular weight subcomponent.
    Poon MC; Ratnoff OD
    Blood; 1977 Sep; 50(3):367-76. PubMed ID: 301759
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies of factor VIII in haemophilia and von Willebrand's disease.
    Gralnick HR; Coller BS; Marchesi SL
    Nat New Biol; 1973 Aug; 244(139):281-2. PubMed ID: 4199570
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clotting on structure and function of human factor VIII.
    Gordon NR; Shulman NR
    Ann N Y Acad Sci; 1975 Jan; 240():79-83. PubMed ID: 1078623
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular platelet factor VIII antigen and von Willebrand factor.
    Nachman RL; Jaffe EA
    J Exp Med; 1975 May; 141(5):1101-13. PubMed ID: 1168691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-haemophilic factor, normal and abnormal.
    Bennett B
    Br J Haematol; 1974 Jan; 26(1):1-7. PubMed ID: 4604099
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein.
    Gralnick HR; Coller BS
    Blood; 1975 Sep; 46(3):417-30. PubMed ID: 1080062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 18. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 19. The cold-insoluble globulin of plasma and its relationship to factor VIII.
    Cooper HA; Wagner RH; Mosesson MW
    J Lab Clin Med; 1974 Aug; 84(2):258-63. PubMed ID: 4135593
    [No Abstract]   [Full Text] [Related]  

  • 20. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.